(Q38996872)

English

Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features

scientific article published on 11 June 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

M Zuberi

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

R Mir

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

J Das

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

I Ahmad

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

J Javid

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

P Yadav

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

M Masroor

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

S Ahmad

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

P C Ray

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A Saxena

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

11 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

779-787

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

New perspectives on targeted therapy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The role of microRNA-200 in progression of human colorectal and breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA expression profiles in serous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA signatures in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNAs as regulators of epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

miR-200-containing extracellular vesicles promote breast cancer cell metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The role of microRNAs in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Cell-free Circulating miRNA Biomarkers in Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Cost-Effectiveness of Early-Initiated Treatment for Advanced-Stage Epithelial Ovarian Cancer Patients

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1303-1

21 January 2018

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to explain the contradiction of microRNA 200c expression and survival in solid tumors? A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA in oral cancer research: future prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating cell-free microRNAs as biomarkers for colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26063644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-015-1303-1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38996872&oldid=2202441855"